Company Filing History:
1 out of 233 
1 out of 48 Years Active: 2019
Title: Michael Firer: Innovator in Opioid Receptor Agonist Peptides
Introduction
Michael Firer is an accomplished inventor based in Karnei Shomron, Israel. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptides that act as delta opioid receptor agonists. His innovative work aims to address medical conditions related to pain management and addiction.
Latest Patents
Michael Firer holds a patent for "Delta receptor agonist peptides and use thereof." This patent describes peptides that are effective as delta opioid receptor agonists and includes compositions comprising these peptides. The methods outlined in the patent target medical conditions that can be treated with an opioid receptor agonist, including pain management and reducing cocaine cravings.
Career Highlights
Throughout his career, Michael Firer has worked with notable institutions, including Bar-Ilan University and Ariel Scientific Innovations Ltd. His research has focused on the therapeutic potential of delta receptor agonists, contributing to advancements in pain relief and addiction treatment.
Collaborations
Michael has collaborated with esteemed colleagues such as Gal Yadid and Rachela Popovtzer. Their combined expertise has furthered the development of innovative solutions in the field of opioid receptor research.
Conclusion
Michael Firer's work in developing delta receptor agonist peptides showcases his commitment to advancing medical science. His contributions have the potential to significantly impact pain management and addiction therapies.